The Valley Desk

NCT04848506 · Interventional trial

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

Overall registry status Enrolling by invitation

Phase 2 · Phase 3

Conditions Symptomatic Hypertrophic Cardiomyopathy (HCM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov